Login

Mitsubishi's vaccine plant in Quebec City sold to local investors

Sprawling Medicago production facility completed last year was never occupied
The Medicago complex, a sprawling property designed to create plant-based vaccines, will be used as a multitenant life science facility, its new ownership duo says. (2300 Estimauville)
The Medicago complex, a sprawling property designed to create plant-based vaccines, will be used as a multitenant life science facility, its new ownership duo says. (2300 Estimauville)
CoStar News
November 8, 2024 | 11:00 P.M.

The Medicago megacomplex, a 700,000-square-foot vaccine production facility completed in 2023 but never occupied, has been sold.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In